QUINIDINE GLUCONATE FOR INJ 80MG/ML USP DIN 00128740
Health Canada record
| Active ingredient(s) | QUINIDINE GLUCONATE 80 MG |
|---|---|
| Dosage form | Liquid |
| Route | Intravenous; Intramuscular |
| Schedule | ETHICAL |
| Class | Human |
| ATC | C01BA01 QUINIDINE |
| Original market date | 31-Dec-1991 |
| Current status date | 13-Aug-1997 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eli Lilly Canada Inc. — licence 100164, currently licensed, last inspection rating C (2026-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing QUINIDINE GLUCONATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00595934 | APO-QUIN-G TAB 325MG | APOTEX INC | Tablet | QUINIDINE GLUCONATE 325 MG | Cancelled Post Market |
| 00311731 | QUINATE TAB 325MG | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | Tablet | QUINIDINE GLUCONATE 325 MG | Cancelled Post Market |
International API supply for QUINIDINE GLUCONATE
1 active FDA Drug Master Files.
Request a quote for QUINIDINE GLUCONATE FOR INJ 80MG/ML USP